Jason D Roberts1, Thomas A Dewland1, James Longoria1, Annette L Fitzpatrick1, Elad Ziv1, Donglei Hu1, Jue Lin1, David V Glidden1, Bruce M Psaty1, Esteban G Burchard1, Elizabeth H Blackburn1, Jeffrey E Olgin1, Susan R Heckbert1, Gregory M Marcus2. 1. From the Section of Cardiac Electrophysiology, Division of Cardiology, Department of Medicine (J.D.R., T.A.D., J.E.O., G.M.M.), Institute of Human Genetics and Department of Medicine (E.Z., D.H.), Department of Biochemistry and Biophysics (J.L., E.H.B.), Department of Epidemiology and Biostatistics (D.V.G.), Department of Medicine (E.G.B.), and Department of Bioengineering and Therapeutic Sciences (E.G.B.), University of California, San Francisco; Division of Cardiovascular Surgery, Sutter Health, Sacramento, CA (J.L.); Department of Epidemiology (A.L.F., S.R.H.) and Cardiovascular Health Research Unit (B.M.P., S.R.H.), University of Washington, Seattle; and Departments of Medicine and Health Services, University of Washington and Group Health Research Institute, Group Health, Seattle (B.M.P., S.R.H.). 2. From the Section of Cardiac Electrophysiology, Division of Cardiology, Department of Medicine (J.D.R., T.A.D., J.E.O., G.M.M.), Institute of Human Genetics and Department of Medicine (E.Z., D.H.), Department of Biochemistry and Biophysics (J.L., E.H.B.), Department of Epidemiology and Biostatistics (D.V.G.), Department of Medicine (E.G.B.), and Department of Bioengineering and Therapeutic Sciences (E.G.B.), University of California, San Francisco; Division of Cardiovascular Surgery, Sutter Health, Sacramento, CA (J.L.); Department of Epidemiology (A.L.F., S.R.H.) and Cardiovascular Health Research Unit (B.M.P., S.R.H.), University of Washington, Seattle; and Departments of Medicine and Health Services, University of Washington and Group Health Research Institute, Group Health, Seattle (B.M.P., S.R.H.). marcusg@medicine.ucsf.edu.
Abstract
BACKGROUND: Advanced age is the most important risk factor for atrial fibrillation (AF); however, the mechanism remains unknown. Telomeres, regions of DNA that shorten with cell division, are considered reliable markers of biological aging. We sought to examine the association between leukocyte telomere length (LTL) and incident AF in a large population-based cohort using direct LTL measurements and genetic data. To further explore our findings, we compared atrial cell telomere length and LTL in cardiac surgery patients. METHODS AND RESULTS: Mean LTL and the TERT rs2736100 single nucleotide polymorphism were assessed as predictors of incident AF in the Cardiovascular Health Study (CHS). Among the surgical patients, within subject comparison of atrial cell telomere length versus LTL was assessed. Among 1639 CHS participants, we observed no relationship between mean LTL and incident AF before and after adjustment for potential confounders (adjusted hazard ratio, 1.09; 95% confidence interval: 0.92-1.29; P=0.299); chronologic age remained strongly associated with AF in the same model. No association was observed between the TERT rs2736100 single nucleotide polymorphism and incident AF (adjusted hazard ratio: 0.95; 95% confidence interval: 0.88-1.04; P=0.265). In 35 cardiac surgery patients (26 with AF), atrial cell telomere length was longer than LTL (1.19 ± 0.20 versus 1.02 ± 0.25 [T/S ratio], P<0.001), a finding that remained consistent within the AF subgroup. CONCLUSIONS: Our study revealed no evidence of an association between LTL and incident AF and no evidence of relative atrial cell telomere shortening in AF. Chronological aging independent of biological markers of aging is the primary risk factor for AF.
BACKGROUND: Advanced age is the most important risk factor for atrial fibrillation (AF); however, the mechanism remains unknown. Telomeres, regions of DNA that shorten with cell division, are considered reliable markers of biological aging. We sought to examine the association between leukocyte telomere length (LTL) and incident AF in a large population-based cohort using direct LTL measurements and genetic data. To further explore our findings, we compared atrial cell telomere length and LTL in cardiac surgery patients. METHODS AND RESULTS: Mean LTL and the TERTrs2736100 single nucleotide polymorphism were assessed as predictors of incident AF in the Cardiovascular Health Study (CHS). Among the surgical patients, within subject comparison of atrial cell telomere length versus LTL was assessed. Among 1639 CHSparticipants, we observed no relationship between mean LTL and incident AF before and after adjustment for potential confounders (adjusted hazard ratio, 1.09; 95% confidence interval: 0.92-1.29; P=0.299); chronologic age remained strongly associated with AF in the same model. No association was observed between the TERTrs2736100 single nucleotide polymorphism and incident AF (adjusted hazard ratio: 0.95; 95% confidence interval: 0.88-1.04; P=0.265). In 35 cardiac surgery patients (26 with AF), atrial cell telomere length was longer than LTL (1.19 ± 0.20 versus 1.02 ± 0.25 [T/S ratio], P<0.001), a finding that remained consistent within the AF subgroup. CONCLUSIONS: Our study revealed no evidence of an association between LTL and incident AF and no evidence of relative atrial cell telomere shortening in AF. Chronological aging independent of biological markers of aging is the primary risk factor for AF.
Authors: Scott W Brouilette; Jasbir S Moore; Alex D McMahon; John R Thompson; Ian Ford; James Shepherd; Chris J Packard; Nilesh J Samani Journal: Lancet Date: 2007-01-13 Impact factor: 79.321
Authors: Yoko Miyasaka; Marion E Barnes; Bernard J Gersh; Stephen S Cha; Kent R Bailey; Walter P Abhayaratna; James B Seward; Teresa S M Tsang Journal: Circulation Date: 2006-07-03 Impact factor: 29.690
Authors: L P Fried; N O Borhani; P Enright; C D Furberg; J M Gardin; R A Kronmal; L H Kuller; T A Manolio; M B Mittelmark; A Newman Journal: Ann Epidemiol Date: 1991-02 Impact factor: 3.797
Authors: Annette L Fitzpatrick; Richard A Kronmal; Jeffrey P Gardner; Bruce M Psaty; Nancy S Jenny; Russell P Tracy; Jeremy Walston; Masyuki Kimura; Abraham Aviv Journal: Am J Epidemiol Date: 2006-10-16 Impact factor: 4.897
Authors: D G Ives; A L Fitzpatrick; D E Bild; B M Psaty; L H Kuller; P M Crowley; R G Cruise; S Theroux Journal: Ann Epidemiol Date: 1995-07 Impact factor: 3.797
Authors: B M Psaty; T A Manolio; L H Kuller; R A Kronmal; M Cushman; L P Fried; R White; C D Furberg; P M Rautaharju Journal: Circulation Date: 1997-10-07 Impact factor: 29.690
Authors: Jason D Roberts; Eric Vittinghoff; Ake T Lu; Alvaro Alonso; Biqi Wang; Colleen M Sitlani; Pedrum Mohammadi-Shemirani; Myriam Fornage; Jelena Kornej; Jennifer A Brody; Dan E Arking; Honghuang Lin; Susan R Heckbert; Ivana Prokic; Mohsen Ghanbari; Allan C Skanes; Traci M Bartz; Marco V Perez; Kent D Taylor; Steven A Lubitz; Patrick T Ellinor; Kathryn L Lunetta; James S Pankow; Guillaume Paré; Nona Sotoodehnia; Emelia J Benjamin; Steve Horvath; Gregory M Marcus Journal: Circulation Date: 2021-09-30 Impact factor: 39.918
Authors: Jan Bressler; Nora Franceschini; Ellen W Demerath; Thomas H Mosley; Aaron R Folsom; Eric Boerwinkle Journal: BMC Med Genet Date: 2015-07-23 Impact factor: 2.103
Authors: Laila Staerk; Biqi Wang; Kathryn L Lunetta; Robert H Helm; Darae Ko; Jason A Sherer; Patrick T Ellinor; Steven A Lubitz; David D McManus; Ramachandran S Vasan; Emelia J Benjamin; Ludovic Trinquart Journal: J Am Heart Assoc Date: 2017-11-14 Impact factor: 5.501
Authors: Joylene E Siland; Bastiaan Geelhoed; Isabelle C van Gelder; Pim van der Harst; Michiel Rienstra Journal: PLoS One Date: 2017-02-03 Impact factor: 3.240
Authors: Iris Teubel; Elena Elchinova; Santiago Roura; Marco A Fernández; Carolina Gálvez-Montón; Pedro Moliner; Marta de Antonio; Josep Lupón; Antoni Bayés-Genís Journal: J Transl Med Date: 2018-02-20 Impact factor: 5.531
Authors: Shalini Dixit; Mary A Whooley; Eric Vittinghoff; Jason D Roberts; Susan R Heckbert; Annette L Fitzpatrick; Jue Lin; Cindy Leung; Kenneth J Mukamal; Gregory M Marcus Journal: Sci Rep Date: 2019-02-05 Impact factor: 4.379